You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Risperidone improves restricted, repetitive, and stereotyped behaviour in autistic children and adolescents

http://dx.doi.org/10.1136/ebmh.9.1.6

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    McDougle CJ, Hollway J, Scahill L, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005;162:1142–8.OpenUrlCrossRefPubMedWeb of Science

    Q Does risperidone improve repetitive behaviour and social and communication impairment in children and adolescents with autism?

    METHODS

    Embedded ImageDesign:

    Randomised controlled trial.

    Embedded ImageAllocation:

    Not stated.

    Embedded ImageBlinding:

    Double blind.

    Embedded ImageFollow up period:

    Eight weeks.

    Embedded ImageSetting:

    Five universities, USA; time period not stated.

    Embedded ImagePatients:

    101 children and adolescents aged 12–17 years with autism and impairing behavioural symptoms (DSM-IV, Autism Diagnostic Interview (revised); mean age 8.8 years; 82% male). Exclusions: not stated.

    Embedded ImageIntervention:

    Risperidone (0.5 to 3.5 mg/day); placebo.

    Embedded ImageOutcomes:

    Symptomatic behaviours (modified parent rated Ritvo-Freeman …

    View Full Text

    Footnotes

    • For correspondence: Dr C J McDougle, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202-4800, USA; cmcdougl{at}iupui.edu

    • Sources of funding: National Institute of Health, USA.